FDG PET has emerged as an important clinical imaging modality for diagnosing and staging cancer. However, the impact of FDG PET on staging and managing patients with breast cancer from the referring physician's point of view is unknown.
Ahmanson Biological Imaging Center/Nuclear Medicine Clinic, Department of Molecular and Medical Pharmacology, UCLA School of Medicine, University of California, Los Angeles, USA.
